IUC26590-87

Abstract Code: IUC26590-87   Outcomes of Novel Systemic Therapies in Advanced Upper Tract Urothelial Carcinoma: A systematic Review and Meta-Analysis D’arienzo 1, D. Incognito 2, S. Facchini 3, C. Barraco 1, A. Nicastro 1, M. Berretta 4, G. Facchini 1 (1)...

IUC26589-95

Abstract Code: IUC26589-95   First-Line or Maintenance Immune Checkpoint Inhibitors in Older Patients with Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis Incognito 1, A. D’arienzo 2, C. Barraco 2, A. Nicastro 2, S. Facchini 3, G....

IUC26569-93

Abstract Code: IUC26569-93   Enfortumab-Vedotin with Pembrolizumab vs platinum-based therapy for advanced urothelial cancer in Oxford. Al Kharusi 1, S. San Ti 1, A. Protheroe 1, M. Tuthill 1 (1) Oxford University Hospitals NHS Foundation Trust – United...

IUC26529-89

Abstract Code: IUC26529-89   Sex Differences in Enfortumab Vedotin Efficacy and NECTIN-4 Levels in Metastatic Urothelial Cancer Taha 1, A. Alpert 2, A. Rizzo 3, F. Ciccimarra 3, J. Bellmunt 4, S. Gupta 5, R. Kanesvaran 6, Y. Urun 7, M. Santoni 8, I. Waldhorn 2...

IUC25980-89

Abstract Code: IUC25980-89   Impact of Ureteroscopy on Diagnostic Pathways and Radical Nephroureterectomy Outcomes in Upper Tract Urothelial Carcinoma Maleki 1, L.F.C. Yu 1, H. Janebdar 1, J. Armitage 1 (1) Addenbrooke’s Hospital, Cambridge – United...
error: Content is protected !!